nodes	percent_of_prediction	percent_of_DWPC	metapath
Degarelix—Body temperature increased—Sunitinib—kidney cancer	0.00081	0.00081	CcSEcCtD
Degarelix—Abdominal pain—Sunitinib—kidney cancer	0.00081	0.00081	CcSEcCtD
Degarelix—Diarrhoea—Erlotinib—kidney cancer	0.000809	0.000809	CcSEcCtD
Degarelix—Hypotension—Vincristine—kidney cancer	0.000809	0.000809	CcSEcCtD
Degarelix—Nervous system disorder—Gemcitabine—kidney cancer	0.000806	0.000806	CcSEcCtD
Degarelix—Feeling abnormal—Dactinomycin—kidney cancer	0.000799	0.000799	CcSEcCtD
Degarelix—Skin disorder—Gemcitabine—kidney cancer	0.000798	0.000798	CcSEcCtD
Degarelix—Vision blurred—Paclitaxel—kidney cancer	0.000794	0.000794	CcSEcCtD
Degarelix—Hyperhidrosis—Gemcitabine—kidney cancer	0.000794	0.000794	CcSEcCtD
Degarelix—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000793	0.000793	CcSEcCtD
Degarelix—Hot flush—Doxorubicin—kidney cancer	0.000792	0.000792	CcSEcCtD
Degarelix—Hypoaesthesia—Capecitabine—kidney cancer	0.000791	0.000791	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000789	0.000789	CcSEcCtD
Degarelix—Urinary tract disorder—Capecitabine—kidney cancer	0.000785	0.000785	CcSEcCtD
Degarelix—Menopausal symptoms—Doxorubicin—kidney cancer	0.000785	0.000785	CcSEcCtD
Degarelix—Hypersensitivity—Sorafenib—kidney cancer	0.000784	0.000784	CcSEcCtD
Degarelix—Insomnia—Vincristine—kidney cancer	0.000783	0.000783	CcSEcCtD
Degarelix—Oedema peripheral—Capecitabine—kidney cancer	0.000783	0.000783	CcSEcCtD
Degarelix—Vomiting—Vinblastine—kidney cancer	0.000783	0.000783	CcSEcCtD
Degarelix—Dizziness—Erlotinib—kidney cancer	0.000782	0.000782	CcSEcCtD
Degarelix—Ill-defined disorder—Paclitaxel—kidney cancer	0.000782	0.000782	CcSEcCtD
Degarelix—Vomiting—Everolimus—kidney cancer	0.00078	0.00078	CcSEcCtD
Degarelix—Anaemia—Paclitaxel—kidney cancer	0.000779	0.000779	CcSEcCtD
Degarelix—Urethral disorder—Capecitabine—kidney cancer	0.000779	0.000779	CcSEcCtD
Degarelix—Renal impairment—Doxorubicin—kidney cancer	0.000778	0.000778	CcSEcCtD
Degarelix—Rash—Everolimus—kidney cancer	0.000773	0.000773	CcSEcCtD
Degarelix—Dermatitis—Everolimus—kidney cancer	0.000772	0.000772	CcSEcCtD
Degarelix—Headache—Vinblastine—kidney cancer	0.000771	0.000771	CcSEcCtD
Degarelix—Headache—Everolimus—kidney cancer	0.000768	0.000768	CcSEcCtD
Degarelix—Hypotension—Gemcitabine—kidney cancer	0.000768	0.000768	CcSEcCtD
Degarelix—Abdominal pain—Dactinomycin—kidney cancer	0.000766	0.000766	CcSEcCtD
Degarelix—Body temperature increased—Dactinomycin—kidney cancer	0.000766	0.000766	CcSEcCtD
Degarelix—Asthenia—Sorafenib—kidney cancer	0.000764	0.000764	CcSEcCtD
Degarelix—Malaise—Paclitaxel—kidney cancer	0.00076	0.00076	CcSEcCtD
Degarelix—Cardiac failure—Doxorubicin—kidney cancer	0.000759	0.000759	CcSEcCtD
Degarelix—Hypersensitivity—Sunitinib—kidney cancer	0.000754	0.000754	CcSEcCtD
Degarelix—Decreased appetite—Vincristine—kidney cancer	0.000753	0.000753	CcSEcCtD
Degarelix—Pruritus—Sorafenib—kidney cancer	0.000753	0.000753	CcSEcCtD
Degarelix—Vomiting—Erlotinib—kidney cancer	0.000752	0.000752	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000749	0.000749	CcSEcCtD
Degarelix—Gastrointestinal disorder—Vincristine—kidney cancer	0.000748	0.000748	CcSEcCtD
Degarelix—Fatigue—Vincristine—kidney cancer	0.000747	0.000747	CcSEcCtD
Degarelix—Rash—Erlotinib—kidney cancer	0.000746	0.000746	CcSEcCtD
Degarelix—Dermatitis—Erlotinib—kidney cancer	0.000745	0.000745	CcSEcCtD
Degarelix—Palpitations—Paclitaxel—kidney cancer	0.000745	0.000745	CcSEcCtD
Degarelix—Insomnia—Gemcitabine—kidney cancer	0.000743	0.000743	CcSEcCtD
Degarelix—Eye disorder—Capecitabine—kidney cancer	0.000743	0.000743	CcSEcCtD
Degarelix—Headache—Erlotinib—kidney cancer	0.000741	0.000741	CcSEcCtD
Degarelix—Constipation—Vincristine—kidney cancer	0.000741	0.000741	CcSEcCtD
Degarelix—Pain—Vincristine—kidney cancer	0.000741	0.000741	CcSEcCtD
Degarelix—Cardiac disorder—Capecitabine—kidney cancer	0.000737	0.000737	CcSEcCtD
Degarelix—Asthenia—Sunitinib—kidney cancer	0.000735	0.000735	CcSEcCtD
Degarelix—Dyspnoea—Gemcitabine—kidney cancer	0.000733	0.000733	CcSEcCtD
Degarelix—Nausea—Vinblastine—kidney cancer	0.000731	0.000731	CcSEcCtD
Degarelix—Nausea—Everolimus—kidney cancer	0.000728	0.000728	CcSEcCtD
Degarelix—Diarrhoea—Sorafenib—kidney cancer	0.000728	0.000728	CcSEcCtD
Degarelix—Hypertension—Paclitaxel—kidney cancer	0.000728	0.000728	CcSEcCtD
Degarelix—Pruritus—Sunitinib—kidney cancer	0.000725	0.000725	CcSEcCtD
Degarelix—Angiopathy—Capecitabine—kidney cancer	0.000721	0.000721	CcSEcCtD
Degarelix—Immune system disorder—Capecitabine—kidney cancer	0.000718	0.000718	CcSEcCtD
Degarelix—Arthralgia—Paclitaxel—kidney cancer	0.000718	0.000718	CcSEcCtD
Degarelix—Mediastinal disorder—Capecitabine—kidney cancer	0.000716	0.000716	CcSEcCtD
Degarelix—Decreased appetite—Gemcitabine—kidney cancer	0.000714	0.000714	CcSEcCtD
Degarelix—Hypersensitivity—Dactinomycin—kidney cancer	0.000714	0.000714	CcSEcCtD
Degarelix—Chills—Capecitabine—kidney cancer	0.000713	0.000713	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000713	0.000713	CcSEcCtD
Degarelix—Arrhythmia—Capecitabine—kidney cancer	0.00071	0.00071	CcSEcCtD
Degarelix—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000709	0.000709	CcSEcCtD
Degarelix—Discomfort—Paclitaxel—kidney cancer	0.000709	0.000709	CcSEcCtD
Degarelix—Fatigue—Gemcitabine—kidney cancer	0.000708	0.000708	CcSEcCtD
Degarelix—Gastrointestinal pain—Vincristine—kidney cancer	0.000708	0.000708	CcSEcCtD
Degarelix—Dizziness—Sorafenib—kidney cancer	0.000704	0.000704	CcSEcCtD
Degarelix—Pain—Gemcitabine—kidney cancer	0.000703	0.000703	CcSEcCtD
Degarelix—Constipation—Gemcitabine—kidney cancer	0.000703	0.000703	CcSEcCtD
Degarelix—Nausea—Erlotinib—kidney cancer	0.000703	0.000703	CcSEcCtD
Degarelix—Alopecia—Capecitabine—kidney cancer	0.000702	0.000702	CcSEcCtD
Degarelix—Dry mouth—Paclitaxel—kidney cancer	0.000702	0.000702	CcSEcCtD
Degarelix—Diarrhoea—Sunitinib—kidney cancer	0.000701	0.000701	CcSEcCtD
Degarelix—Mental disorder—Capecitabine—kidney cancer	0.000696	0.000696	CcSEcCtD
Degarelix—Asthenia—Dactinomycin—kidney cancer	0.000696	0.000696	CcSEcCtD
Degarelix—Malnutrition—Capecitabine—kidney cancer	0.000692	0.000692	CcSEcCtD
Degarelix—Erythema—Capecitabine—kidney cancer	0.000692	0.000692	CcSEcCtD
Degarelix—Anaphylactic shock—Paclitaxel—kidney cancer	0.000688	0.000688	CcSEcCtD
Degarelix—Abdominal pain—Vincristine—kidney cancer	0.000685	0.000685	CcSEcCtD
Degarelix—Body temperature increased—Vincristine—kidney cancer	0.000685	0.000685	CcSEcCtD
Degarelix—Dizziness—Sunitinib—kidney cancer	0.000677	0.000677	CcSEcCtD
Degarelix—Feeling abnormal—Gemcitabine—kidney cancer	0.000677	0.000677	CcSEcCtD
Degarelix—Vomiting—Sorafenib—kidney cancer	0.000677	0.000677	CcSEcCtD
Degarelix—Nervous system disorder—Paclitaxel—kidney cancer	0.000675	0.000675	CcSEcCtD
Degarelix—Rash—Sorafenib—kidney cancer	0.000671	0.000671	CcSEcCtD
Degarelix—Dermatitis—Sorafenib—kidney cancer	0.00067	0.00067	CcSEcCtD
Degarelix—Back pain—Capecitabine—kidney cancer	0.000669	0.000669	CcSEcCtD
Degarelix—Breast disorder—Doxorubicin—kidney cancer	0.000669	0.000669	CcSEcCtD
Degarelix—Skin disorder—Paclitaxel—kidney cancer	0.000668	0.000668	CcSEcCtD
Degarelix—Headache—Sorafenib—kidney cancer	0.000667	0.000667	CcSEcCtD
Degarelix—Muscle spasms—Capecitabine—kidney cancer	0.000665	0.000665	CcSEcCtD
Degarelix—Hyperhidrosis—Paclitaxel—kidney cancer	0.000665	0.000665	CcSEcCtD
Degarelix—Diarrhoea—Dactinomycin—kidney cancer	0.000663	0.000663	CcSEcCtD
Degarelix—Muscular weakness—Doxorubicin—kidney cancer	0.000653	0.000653	CcSEcCtD
Degarelix—Vision blurred—Capecitabine—kidney cancer	0.000652	0.000652	CcSEcCtD
Degarelix—Vomiting—Sunitinib—kidney cancer	0.000651	0.000651	CcSEcCtD
Degarelix—Body temperature increased—Gemcitabine—kidney cancer	0.00065	0.00065	CcSEcCtD
Degarelix—Rash—Sunitinib—kidney cancer	0.000646	0.000646	CcSEcCtD
Degarelix—Dermatitis—Sunitinib—kidney cancer	0.000645	0.000645	CcSEcCtD
Degarelix—Hypotension—Paclitaxel—kidney cancer	0.000643	0.000643	CcSEcCtD
Degarelix—Ill-defined disorder—Capecitabine—kidney cancer	0.000642	0.000642	CcSEcCtD
Degarelix—Headache—Sunitinib—kidney cancer	0.000642	0.000642	CcSEcCtD
Degarelix—Anaemia—Capecitabine—kidney cancer	0.000639	0.000639	CcSEcCtD
Degarelix—Hypersensitivity—Vincristine—kidney cancer	0.000638	0.000638	CcSEcCtD
Degarelix—Nausea—Sorafenib—kidney cancer	0.000632	0.000632	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000627	0.000627	CcSEcCtD
Degarelix—Malaise—Capecitabine—kidney cancer	0.000624	0.000624	CcSEcCtD
Degarelix—Insomnia—Paclitaxel—kidney cancer	0.000622	0.000622	CcSEcCtD
Degarelix—Asthenia—Vincristine—kidney cancer	0.000621	0.000621	CcSEcCtD
Degarelix—Vomiting—Dactinomycin—kidney cancer	0.000616	0.000616	CcSEcCtD
Degarelix—Dyspnoea—Paclitaxel—kidney cancer	0.000613	0.000613	CcSEcCtD
Degarelix—Palpitations—Capecitabine—kidney cancer	0.000611	0.000611	CcSEcCtD
Degarelix—Rash—Dactinomycin—kidney cancer	0.000611	0.000611	CcSEcCtD
Degarelix—Nausea—Sunitinib—kidney cancer	0.000608	0.000608	CcSEcCtD
Degarelix—Dysuria—Doxorubicin—kidney cancer	0.000598	0.000598	CcSEcCtD
Degarelix—Decreased appetite—Paclitaxel—kidney cancer	0.000598	0.000598	CcSEcCtD
Degarelix—Hypertension—Capecitabine—kidney cancer	0.000597	0.000597	CcSEcCtD
Degarelix—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000594	0.000594	CcSEcCtD
Degarelix—Fatigue—Paclitaxel—kidney cancer	0.000593	0.000593	CcSEcCtD
Degarelix—Diarrhoea—Vincristine—kidney cancer	0.000593	0.000593	CcSEcCtD
Degarelix—Pollakiuria—Doxorubicin—kidney cancer	0.000591	0.000591	CcSEcCtD
Degarelix—Asthenia—Gemcitabine—kidney cancer	0.00059	0.00059	CcSEcCtD
Degarelix—Arthralgia—Capecitabine—kidney cancer	0.000589	0.000589	CcSEcCtD
Degarelix—Pain—Paclitaxel—kidney cancer	0.000588	0.000588	CcSEcCtD
Degarelix—Constipation—Paclitaxel—kidney cancer	0.000588	0.000588	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000585	0.000585	CcSEcCtD
Degarelix—Weight increased—Doxorubicin—kidney cancer	0.000582	0.000582	CcSEcCtD
Degarelix—Discomfort—Capecitabine—kidney cancer	0.000582	0.000582	CcSEcCtD
Degarelix—Pruritus—Gemcitabine—kidney cancer	0.000581	0.000581	CcSEcCtD
Degarelix—Weight decreased—Doxorubicin—kidney cancer	0.000579	0.000579	CcSEcCtD
Degarelix—Hyperglycaemia—Doxorubicin—kidney cancer	0.000577	0.000577	CcSEcCtD
Degarelix—Dry mouth—Capecitabine—kidney cancer	0.000576	0.000576	CcSEcCtD
Degarelix—Nausea—Dactinomycin—kidney cancer	0.000576	0.000576	CcSEcCtD
Degarelix—Dizziness—Vincristine—kidney cancer	0.000573	0.000573	CcSEcCtD
Degarelix—Feeling abnormal—Paclitaxel—kidney cancer	0.000567	0.000567	CcSEcCtD
Degarelix—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000563	0.000563	CcSEcCtD
Degarelix—Diarrhoea—Gemcitabine—kidney cancer	0.000562	0.000562	CcSEcCtD
Degarelix—Renal failure—Doxorubicin—kidney cancer	0.000561	0.000561	CcSEcCtD
Degarelix—Urinary tract infection—Doxorubicin—kidney cancer	0.000555	0.000555	CcSEcCtD
Degarelix—Nervous system disorder—Capecitabine—kidney cancer	0.000554	0.000554	CcSEcCtD
Degarelix—Vomiting—Vincristine—kidney cancer	0.000551	0.000551	CcSEcCtD
Degarelix—Skin disorder—Capecitabine—kidney cancer	0.000548	0.000548	CcSEcCtD
Degarelix—Urticaria—Paclitaxel—kidney cancer	0.000547	0.000547	CcSEcCtD
Degarelix—Rash—Vincristine—kidney cancer	0.000546	0.000546	CcSEcCtD
Degarelix—Hyperhidrosis—Capecitabine—kidney cancer	0.000546	0.000546	CcSEcCtD
Degarelix—Dermatitis—Vincristine—kidney cancer	0.000546	0.000546	CcSEcCtD
Degarelix—Abdominal pain—Paclitaxel—kidney cancer	0.000544	0.000544	CcSEcCtD
Degarelix—Body temperature increased—Paclitaxel—kidney cancer	0.000544	0.000544	CcSEcCtD
Degarelix—Headache—Vincristine—kidney cancer	0.000543	0.000543	CcSEcCtD
Degarelix—Hepatobiliary disease—Doxorubicin—kidney cancer	0.00054	0.00054	CcSEcCtD
Degarelix—Hypotension—Capecitabine—kidney cancer	0.000528	0.000528	CcSEcCtD
Degarelix—Vomiting—Gemcitabine—kidney cancer	0.000522	0.000522	CcSEcCtD
Degarelix—Rash—Gemcitabine—kidney cancer	0.000518	0.000518	CcSEcCtD
Degarelix—Dermatitis—Gemcitabine—kidney cancer	0.000518	0.000518	CcSEcCtD
Degarelix—Headache—Gemcitabine—kidney cancer	0.000515	0.000515	CcSEcCtD
Degarelix—Nausea—Vincristine—kidney cancer	0.000514	0.000514	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000514	0.000514	CcSEcCtD
Degarelix—Insomnia—Capecitabine—kidney cancer	0.000511	0.000511	CcSEcCtD
Degarelix—Hypoaesthesia—Doxorubicin—kidney cancer	0.00051	0.00051	CcSEcCtD
Degarelix—Hypersensitivity—Paclitaxel—kidney cancer	0.000507	0.000507	CcSEcCtD
Degarelix—Urinary tract disorder—Doxorubicin—kidney cancer	0.000506	0.000506	CcSEcCtD
Degarelix—Oedema peripheral—Doxorubicin—kidney cancer	0.000505	0.000505	CcSEcCtD
Degarelix—Dyspnoea—Capecitabine—kidney cancer	0.000503	0.000503	CcSEcCtD
Degarelix—Urethral disorder—Doxorubicin—kidney cancer	0.000502	0.000502	CcSEcCtD
Degarelix—Asthenia—Paclitaxel—kidney cancer	0.000494	0.000494	CcSEcCtD
Degarelix—Decreased appetite—Capecitabine—kidney cancer	0.000491	0.000491	CcSEcCtD
Degarelix—Nausea—Gemcitabine—kidney cancer	0.000488	0.000488	CcSEcCtD
Degarelix—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000487	0.000487	CcSEcCtD
Degarelix—Fatigue—Capecitabine—kidney cancer	0.000487	0.000487	CcSEcCtD
Degarelix—Pruritus—Paclitaxel—kidney cancer	0.000487	0.000487	CcSEcCtD
Degarelix—Pain—Capecitabine—kidney cancer	0.000483	0.000483	CcSEcCtD
Degarelix—Constipation—Capecitabine—kidney cancer	0.000483	0.000483	CcSEcCtD
Degarelix—Eye disorder—Doxorubicin—kidney cancer	0.000479	0.000479	CcSEcCtD
Degarelix—Cardiac disorder—Doxorubicin—kidney cancer	0.000475	0.000475	CcSEcCtD
Degarelix—Diarrhoea—Paclitaxel—kidney cancer	0.000471	0.000471	CcSEcCtD
Degarelix—Feeling abnormal—Capecitabine—kidney cancer	0.000465	0.000465	CcSEcCtD
Degarelix—Angiopathy—Doxorubicin—kidney cancer	0.000465	0.000465	CcSEcCtD
Degarelix—Immune system disorder—Doxorubicin—kidney cancer	0.000463	0.000463	CcSEcCtD
Degarelix—Gastrointestinal pain—Capecitabine—kidney cancer	0.000462	0.000462	CcSEcCtD
Degarelix—Mediastinal disorder—Doxorubicin—kidney cancer	0.000462	0.000462	CcSEcCtD
Degarelix—Chills—Doxorubicin—kidney cancer	0.00046	0.00046	CcSEcCtD
Degarelix—Arrhythmia—Doxorubicin—kidney cancer	0.000458	0.000458	CcSEcCtD
Degarelix—Dizziness—Paclitaxel—kidney cancer	0.000455	0.000455	CcSEcCtD
Degarelix—Alopecia—Doxorubicin—kidney cancer	0.000453	0.000453	CcSEcCtD
Degarelix—Mental disorder—Doxorubicin—kidney cancer	0.000449	0.000449	CcSEcCtD
Degarelix—Urticaria—Capecitabine—kidney cancer	0.000449	0.000449	CcSEcCtD
Degarelix—Abdominal pain—Capecitabine—kidney cancer	0.000446	0.000446	CcSEcCtD
Degarelix—Body temperature increased—Capecitabine—kidney cancer	0.000446	0.000446	CcSEcCtD
Degarelix—Erythema—Doxorubicin—kidney cancer	0.000446	0.000446	CcSEcCtD
Degarelix—Malnutrition—Doxorubicin—kidney cancer	0.000446	0.000446	CcSEcCtD
Degarelix—Vomiting—Paclitaxel—kidney cancer	0.000437	0.000437	CcSEcCtD
Degarelix—Rash—Paclitaxel—kidney cancer	0.000434	0.000434	CcSEcCtD
Degarelix—Dermatitis—Paclitaxel—kidney cancer	0.000433	0.000433	CcSEcCtD
Degarelix—Back pain—Doxorubicin—kidney cancer	0.000431	0.000431	CcSEcCtD
Degarelix—Headache—Paclitaxel—kidney cancer	0.000431	0.000431	CcSEcCtD
Degarelix—Muscle spasms—Doxorubicin—kidney cancer	0.000429	0.000429	CcSEcCtD
Degarelix—Vision blurred—Doxorubicin—kidney cancer	0.00042	0.00042	CcSEcCtD
Degarelix—Hypersensitivity—Capecitabine—kidney cancer	0.000416	0.000416	CcSEcCtD
Degarelix—Ill-defined disorder—Doxorubicin—kidney cancer	0.000414	0.000414	CcSEcCtD
Degarelix—Anaemia—Doxorubicin—kidney cancer	0.000412	0.000412	CcSEcCtD
Degarelix—Nausea—Paclitaxel—kidney cancer	0.000409	0.000409	CcSEcCtD
Degarelix—Asthenia—Capecitabine—kidney cancer	0.000405	0.000405	CcSEcCtD
Degarelix—Malaise—Doxorubicin—kidney cancer	0.000402	0.000402	CcSEcCtD
Degarelix—Pruritus—Capecitabine—kidney cancer	0.000399	0.000399	CcSEcCtD
Degarelix—Palpitations—Doxorubicin—kidney cancer	0.000394	0.000394	CcSEcCtD
Degarelix—Diarrhoea—Capecitabine—kidney cancer	0.000386	0.000386	CcSEcCtD
Degarelix—Hypertension—Doxorubicin—kidney cancer	0.000385	0.000385	CcSEcCtD
Degarelix—Arthralgia—Doxorubicin—kidney cancer	0.00038	0.00038	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000377	0.000377	CcSEcCtD
Degarelix—Discomfort—Doxorubicin—kidney cancer	0.000375	0.000375	CcSEcCtD
Degarelix—Dizziness—Capecitabine—kidney cancer	0.000373	0.000373	CcSEcCtD
Degarelix—Dry mouth—Doxorubicin—kidney cancer	0.000371	0.000371	CcSEcCtD
Degarelix—Anaphylactic shock—Doxorubicin—kidney cancer	0.000364	0.000364	CcSEcCtD
Degarelix—Vomiting—Capecitabine—kidney cancer	0.000359	0.000359	CcSEcCtD
Degarelix—Nervous system disorder—Doxorubicin—kidney cancer	0.000357	0.000357	CcSEcCtD
Degarelix—Rash—Capecitabine—kidney cancer	0.000356	0.000356	CcSEcCtD
Degarelix—Dermatitis—Capecitabine—kidney cancer	0.000356	0.000356	CcSEcCtD
Degarelix—Headache—Capecitabine—kidney cancer	0.000354	0.000354	CcSEcCtD
Degarelix—Skin disorder—Doxorubicin—kidney cancer	0.000353	0.000353	CcSEcCtD
Degarelix—Hyperhidrosis—Doxorubicin—kidney cancer	0.000352	0.000352	CcSEcCtD
Degarelix—Hypotension—Doxorubicin—kidney cancer	0.00034	0.00034	CcSEcCtD
Degarelix—Nausea—Capecitabine—kidney cancer	0.000335	0.000335	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000332	0.000332	CcSEcCtD
Degarelix—Insomnia—Doxorubicin—kidney cancer	0.000329	0.000329	CcSEcCtD
Degarelix—Dyspnoea—Doxorubicin—kidney cancer	0.000324	0.000324	CcSEcCtD
Degarelix—Decreased appetite—Doxorubicin—kidney cancer	0.000316	0.000316	CcSEcCtD
Degarelix—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000314	0.000314	CcSEcCtD
Degarelix—Fatigue—Doxorubicin—kidney cancer	0.000314	0.000314	CcSEcCtD
Degarelix—Pain—Doxorubicin—kidney cancer	0.000311	0.000311	CcSEcCtD
Degarelix—Constipation—Doxorubicin—kidney cancer	0.000311	0.000311	CcSEcCtD
Degarelix—Feeling abnormal—Doxorubicin—kidney cancer	0.0003	0.0003	CcSEcCtD
Degarelix—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000298	0.000298	CcSEcCtD
Degarelix—Urticaria—Doxorubicin—kidney cancer	0.000289	0.000289	CcSEcCtD
Degarelix—Abdominal pain—Doxorubicin—kidney cancer	0.000288	0.000288	CcSEcCtD
Degarelix—Body temperature increased—Doxorubicin—kidney cancer	0.000288	0.000288	CcSEcCtD
Degarelix—Hypersensitivity—Doxorubicin—kidney cancer	0.000268	0.000268	CcSEcCtD
Degarelix—Asthenia—Doxorubicin—kidney cancer	0.000261	0.000261	CcSEcCtD
Degarelix—Pruritus—Doxorubicin—kidney cancer	0.000257	0.000257	CcSEcCtD
Degarelix—Diarrhoea—Doxorubicin—kidney cancer	0.000249	0.000249	CcSEcCtD
Degarelix—Dizziness—Doxorubicin—kidney cancer	0.000241	0.000241	CcSEcCtD
Degarelix—Vomiting—Doxorubicin—kidney cancer	0.000231	0.000231	CcSEcCtD
Degarelix—Rash—Doxorubicin—kidney cancer	0.000229	0.000229	CcSEcCtD
Degarelix—Dermatitis—Doxorubicin—kidney cancer	0.000229	0.000229	CcSEcCtD
Degarelix—Headache—Doxorubicin—kidney cancer	0.000228	0.000228	CcSEcCtD
Degarelix—Nausea—Doxorubicin—kidney cancer	0.000216	0.000216	CcSEcCtD
